BLFS Q3 2023 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$24M-42.1% YoY

Gross Profit

$12M50.9% margin

Operating Income

-$9M-37.1% margin

Net Income

-$29M-123.6% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-40.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$6M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$411M

Total Liabilities

$79M

Stockholders' Equity

$332M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$41M	-42.1%
Gross Profit	$12M	$14M	-12.7%
Operating Income	-$9M	-$9M	+3.5%
Net Income	-$29M	-$10M	-192.6%

Revenue Segments

Product

$27M45%

Product, Cell Processing

$13M22%

Product, Freezer and Thaw

$13M22%

Service

$4M7%

Rental Revenue

$2M3%